pyrrolidonecarboxylic acid has been researched along with ketotifen in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eliakim, R; Karmeli, F; Okon, E; Rachmilewitz, D | 1 |
Guth, PH; Király, A; Süto, G; Taché, Y | 1 |
Adelson, D; Akiba, Y; Engel, E; Guth, PH; Kaunitz, JD; Kawakubo, K; Taché, Y | 1 |
3 other study(ies) available for pyrrolidonecarboxylic acid and ketotifen
Article | Year |
---|---|
Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.
Topics: Animals; Azepines; Cimetidine; Ethanol; Gastric Acid; Gastric Mucosa; Gastrins; Hydroxyzine; In Vitro Techniques; Ketotifen; Leukotriene B4; Male; Mast Cells; Pepsin A; Peptide Fragments; Platelet Activating Factor; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; SRS-A; Substance P; Triazoles | 1991 |
Ketotifen prevents gastric hyperemia induced by intracisternal thyrotropin-releasing hormone at a low dose.
Topics: Animals; Blood Pressure; Cisterna Magna; Gastric Acid; Gastric Mucosa; Hyperemia; Injections; Ketotifen; Male; Mast Cells; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Thyrotropin-Releasing Hormone; Vascular Resistance | 1997 |
Role of gastric mast cells in the regulation of central TRH analog-induced hyperemia in rats.
Topics: Animals; Blood Pressure; Cell Count; Cell Degranulation; Connective Tissue Cells; Cromolyn Sodium; Dose-Response Relationship, Drug; Gastric Mucosa; Histamine Antagonists; Hyperemia; Injections, Intraventricular; Ketotifen; Male; Mast Cells; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Serotonin Antagonists; Stomach; Thioxanthenes; Thyrotropin-Releasing Hormone; Vascular Resistance; Xanthones | 2005 |